"Patents as Topic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Works about exclusive legal rights or privileges applied to inventions, plants, etc.
| Descriptor ID |
D010330
|
| MeSH Number(s) |
I01.880.604.583.458.650 N03.706.535.518.650
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Patents as Topic".
Below are MeSH descriptors whose meaning is more specific than "Patents as Topic".
This graph shows the total number of publications written about "Patents as Topic" by people in this website by year, and whether "Patents as Topic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 0 | 2 | 2 |
| 2013 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Patents as Topic" by people in Profiles.
-
Pederson T. US companies' COVID patents: Will "the saints go marching in"? FASEB J. 2021 10; 35(10):e21879.
-
Nguyen K, Kempfle JS, Jung DH, McKenna CE. Recent advances in therapeutics and drug delivery for the treatment of inner ear diseases: a patent review (2011-2015). Expert Opin Ther Pat. 2017 Feb; 27(2):191-202.
-
Bhardwaj N, Katyal P, Sharma AK. Suppression of inflammatory and allergic responses by pharmacologically potent fungus Ganoderma lucidum. Recent Pat Inflamm Allergy Drug Discov. 2014; 8(2):104-17.
-
Pezzuto JM, Kondratyuk TP, Ogas T. Resveratrol derivatives: a patent review (2009 - 2012). Expert Opin Ther Pat. 2013 Dec; 23(12):1529-46.
-
Renaud JM, Hayward LJ. Lessons learned from muscle fatigue: implications for treatment of patients with hyperkalemic periodic paralysis. Recent Pat Biotechnol. 2012 Dec; 6(3):184-91.
-
Pederson T. Sense and antisense in biotech: the first antisense DNA company. FASEB J. 2012 Sep; 26(9):3594-601.
-
Ulgen BO, Field MG, Qureshi W, Knight RA, Stephanou A, Latchman DS, Vasquez D, Barry SP, Saravolatz L, Scarabelli GM, Faggian G, Mazzucco A, Saravolatz L, Chen-Scarabelli C, Scarabelli TM. The role of minocycline in ischemia-reperfusion injury: a comprehensive review of an old drug with new implications. Recent Pat Cardiovasc Drug Discov. 2011 May; 6(2):123-32.
-
Nusbaum NJ. Drug development and patent law. N Y State J Med. 1992 Mar; 92(3):86-7.